Quantum Genomics (France) Probability of Future Stock Price Finishing Over 0.0721
| ALQGC Stock | EUR 0.07 0 1.77% |
Quantum |
Quantum Genomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Quantum Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Quantum Genomics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Quantum Genomics generated a negative expected return over the last 90 days | |
| Quantum Genomics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 116.21 K. Net Loss for the year was (17.36 M) with loss before overhead, payroll, taxes, and interest of (12.47 M). | |
| Quantum Genomics SA has accumulated about 5.01 M in cash with (17.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Quantum Genomics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Quantum Stock often depends not only on the future outlook of the current and potential Quantum Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quantum Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 13.6 M |
Quantum Genomics Technical Analysis
Quantum Genomics' future price can be derived by breaking down and analyzing its technical indicators over time. Quantum Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Quantum Genomics SA. In general, you should focus on analyzing Quantum Stock price patterns and their correlations with different microeconomic environments and drivers.
Quantum Genomics Predictive Forecast Models
Quantum Genomics' time-series forecasting models is one of many Quantum Genomics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Quantum Genomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Quantum Genomics
Checking the ongoing alerts about Quantum Genomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Quantum Genomics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Quantum Genomics generated a negative expected return over the last 90 days | |
| Quantum Genomics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 116.21 K. Net Loss for the year was (17.36 M) with loss before overhead, payroll, taxes, and interest of (12.47 M). | |
| Quantum Genomics SA has accumulated about 5.01 M in cash with (17.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Additional Tools for Quantum Stock Analysis
When running Quantum Genomics' price analysis, check to measure Quantum Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quantum Genomics is operating at the current time. Most of Quantum Genomics' value examination focuses on studying past and present price action to predict the probability of Quantum Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quantum Genomics' price. Additionally, you may evaluate how the addition of Quantum Genomics to your portfolios can decrease your overall portfolio volatility.